TheraJect is an AI-driven rare-earth innovation platform integrating materials discovery, bio-extraction, and supply-chain intelligence.
Originally founded in biotechnology, TheraJect has evolved into a next-generation AI/ML platform addressing one of the most critical global challenges: secure, sustainable, and resilient rare-earth supply chains.
Our mission is to accelerate breakthroughs across the entire rare-earth lifecycle—from discovery to extraction to deployment—by combining artificial intelligence, physics-based simulation, and data-driven system modeling.
Our Platform
TheraJect operates a unified AI platform built on three core pillars:
1️⃣ AI-Driven Materials Discovery
- Generative models (VAE, diffusion, GFlowNet) for novel compositions
- Graph neural networks and transformer architectures
- Structure generation (e.g., PyXtal) and surrogate property prediction (e.g., M3GNet, RF)
- High-throughput DFT validation
- Multi-objective optimization for magnetics, stability, cost, and manufacturability
2️⃣ AI-Guided Bio-Extraction (Biomining)
- Lanmodulin-based rare-earth binding and separation
- Protein language models (ESM-2) for sequence representation
- Machine learning prediction (XGBoost / RF) of selectivity and performance
- Immobilization and support-material optimization
- Sustainable and low-impact REE recovery technologies
3️⃣ Digital Twin & Supply-Chain Intelligence
- AI-enabled simulation of rare-earth supply chains
- Extraction and recycling process modeling
- Scenario analysis for geopolitical risk and policy impact
- Optimization of resource flow, cost, and resilience
What We Do
TheraJect develops and deploys an integrated platform that combines:
- Generative AI for materials and molecular design
- Physics-informed modeling and high-throughput simulation
- Protein machine learning for biomining applications
- Data fusion across materials, biological, and industrial datasets
- Multi-objective optimization across performance, cost, and sustainability
This platform enables rapid identification of high-impact candidates across materials discovery, green extraction, and supply-chain optimization.
Strategic Focus
TheraJect’s innovations support:
- U.S. national priorities (critical minerals, clean energy, CHIPS & Science)
- Allied industrial ecosystems in Korea, Japan, and Europe
- Development of resilient and sustainable rare-earth supply chains
Applications include:
- Permanent magnets (NdFeB alternatives, REE-reduced systems)
- Semiconductor materials
- Advanced battery materials
- Rare-earth extraction, recycling, and biomining
Our Origins
TheraJect was originally founded in biomedical engineering, where its founder led the development of dissolving microneedle technologies supported by:
- U.S. National Institutes of Health (NIH)
- National Science Foundation (NSF)
- Bill & Melinda Gates Foundation
This platform was successfully licensed for commercialization.
Today, TheraJect builds on that foundation to apply AI-driven innovation across materials science and industrial systems.